PIMSTONE SIMON N.

CIK 00016200841 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001620084

Recent Transactions

50 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-01−45,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-06-01$17.76/sh+45,000→ 51,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-06-01$38.53/sh−20,745→ 30,255 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-06-01$38.97/sh−7,458→ 6,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-06-01$38.53/sh−1,860→ 13,458 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-06-01$38.78/sh−24,255→ 6,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-01−9,318→ 30,682 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-06-01$7.69/sh+9,318→ 15,318 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$38.37/sh−6,165→ 29,670 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$38.53/sh−12,000→ 6,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$9.85/sh+29,835→ 35,835 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$38.81/sh−23,670→ 6,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-05-31−50,000→ 45,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$17.76/sh+50,000→ 56,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$38.37/sh−23,144→ 32,856 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-05-31−29,835→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-31$38.69/sh−26,856→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-30$39.90/sh−19,000→ 18,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-05-30$38.63/sh−18,006→ 37,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-07$37.13/sh−1,618→ 63,248 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-07$36.94/sh−8,242→ 55,006 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-07$37.01/sh−10,990→ 34,002 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-07$37.13/sh−2,160→ 44,992 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-07$2.68/sh+41,152→ 47,152 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-07−41,152→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-07−30,864→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-03-07$2.59/sh+30,864→ 64,866 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-16$38.87/sh−20,000→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-16$38.29/sh−32,058→ 26,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-15$37.76/sh−33,942→ 58,058 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$39.15/sh−1,000→ 92,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$38.60/sh−47,000→ 93,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$37.91/sh−43,135→ 140,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-10+25,000→ 25,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$30.10/sh−2,500→ 190,635 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$30.55/sh−2,500→ 185,635 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$3.80/sh−2,500→ 193,135 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$30.20/sh−2,500→ 188,135 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$30.60/sh−2,051→ 195,635 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$30.50/sh−2,500→ 183,135 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-08$30.80/sh−2,500→ 193,135 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.55/sh−2,500→ 197,686 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-07−20,576→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.45/sh−4,516→ 214,702 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.60/sh−5,037→ 223,735 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.52/sh−2,500→ 207,686 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.44/sh−4,516→ 210,186 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.50/sh−7,500→ 200,186 total

Companies

Xenon Pharmaceuticals Inc.
Director, President, CEO and Director
$XENE

Recent Filings

Address

C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov